Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

NTLA

Intellia Therapeutics (NTLA)

Intellia Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:NTLA
DateTimeSourceHeadlineSymbolCompany
15/12/201708:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NTLAIntellia Therapeutics Inc
15/12/201704:30Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:NTLAIntellia Therapeutics Inc
15/12/201704:20Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NTLAIntellia Therapeutics Inc
11/12/201723:00GlobeNewswire Inc.Intellia Therapeutics Announces New, Robust Genome Editing Data for Sickle Cell Disease at the American Society of Hematology...NASDAQ:NTLAIntellia Therapeutics Inc
09/12/201709:29Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NTLAIntellia Therapeutics Inc
09/11/201707:52Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:NTLAIntellia Therapeutics Inc
04/11/201702:55Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NTLAIntellia Therapeutics Inc
03/11/201721:05Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NTLAIntellia Therapeutics Inc
03/11/201721:05Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:NTLAIntellia Therapeutics Inc
03/11/201707:30GlobeNewswire Inc.Intellia Therapeutics to Present at November Healthcare Investor ConferencesNASDAQ:NTLAIntellia Therapeutics Inc
02/11/201712:00GlobeNewswire Inc.Intellia Therapeutics Announces Pricing of Public Offering of Common StockNASDAQ:NTLAIntellia Therapeutics Inc
01/11/201722:12Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:NTLAIntellia Therapeutics Inc
01/11/201722:00GlobeNewswire Inc.Intellia Therapeutics Announces Proposed Public Offering of Common StockNASDAQ:NTLAIntellia Therapeutics Inc
31/10/201723:03Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:NTLAIntellia Therapeutics Inc
31/10/201722:42Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NTLAIntellia Therapeutics Inc
31/10/201722:30GlobeNewswire Inc.Intellia Therapeutics Announces Third Quarter 2017 Financial ResultsNASDAQ:NTLAIntellia Therapeutics Inc
31/10/201707:35GlobeNewswire Inc.Intellia Therapeutics to Hold Conference Call to Discuss Third Quarter 2017 EarningsNASDAQ:NTLAIntellia Therapeutics Inc
04/10/201707:35GlobeNewswire Inc.Intellia Therapeutics to Present at October Healthcare Investor ConferencesNASDAQ:NTLAIntellia Therapeutics Inc
26/09/201721:30GlobeNewswire Inc.Intellia Therapeutics Demonstrates Sustained and Durable Genome Editing with CRISPR/Cas9 in One-Year Animal StudyNASDAQ:NTLAIntellia Therapeutics Inc
14/09/201708:30Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NTLAIntellia Therapeutics Inc
08/09/201707:00GlobeNewswire Inc.Intellia Therapeutics to Present at Upcoming September Investor Healthcare ConferencesNASDAQ:NTLAIntellia Therapeutics Inc
02/09/201706:56Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NTLAIntellia Therapeutics Inc
09/08/201706:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NTLAIntellia Therapeutics Inc
02/08/201706:55Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:NTLAIntellia Therapeutics Inc
01/08/201721:37Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NTLAIntellia Therapeutics Inc
01/08/201721:30GlobeNewswire Inc. Intellia Therapeutics Announces Second Quarter 2017 Financial ResultsNASDAQ:NTLAIntellia Therapeutics Inc
26/07/201707:00GlobeNewswire Inc.CRISPR Therapeutics, Intellia Therapeutics, Caribou Biosciences and ERS Genomics Announce Appellate Brief Seeking Reversal of...NASDAQ:NTLAIntellia Therapeutics Inc
26/07/201706:50Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NTLAIntellia Therapeutics Inc
26/07/201706:48Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NTLAIntellia Therapeutics Inc
26/07/201706:47Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:NTLAIntellia Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:NTLA